TickerFacts.

A business in context

ORMP research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-01 · 0001213900-26-106531

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001213900-26-106530

  3. 4 · Ownership change

    Report date 2026-09-24 · 0001213900-26-103540

  4. 4 · Ownership change

    Report date 2026-09-24 · 0001213900-26-103538

  5. 4 · Ownership change

    Report date 2026-09-24 · 0001213900-26-103536

  6. 4 · Ownership change

    Report date 2026-09-24 · 0001213900-26-103535

  7. 8-K · Current report

    Report date 2026-09-15 · 0001213900-26-100929 · Items 5.07

  8. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001213900-26-087361

  9. DEF 14A · Proxy statement

    Report date 2026-09-15 · 0001213900-26-084609

  10. 4 · Ownership change

    Report date 2026-07-01 · 0001213900-26-075070

  11. 4 · Ownership change

    Report date 2026-07-01 · 0001213900-26-075069

  12. 8-K · Current report

    Report date 2026-06-25 · 0001213900-26-073709 · Items 5.03,8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001213900-26-059112

  14. 8-K · Current report

    Report date 2026-03-25 · 0001213900-26-037474 · Items 1.01,2.01

  15. 10-K · Annual report

    Report date 2025-12-31 · 0001213900-26-034835

  16. 8-K · Current report

    Report date 2026-02-19 · 0001012975-26-000195 · Items 1.01,9.01

  17. 8-K · Current report

    Report date 2026-01-12 · 0001213900-26-004382 · Items 1.01,8.01,9.01

  18. 8-K · Current report

    Report date 2026-01-07 · 0001213900-26-001983 · Items 8.01,9.01

  19. 8-K · Current report

    Report date 2025-12-31 · 0001213900-25-127133 · Items 5.02

  20. 8-K · Current report

    Report date 2025-12-30 · 0001012975-25-000992 · Items 8.01

  21. 8-K · Current report

    Report date 2025-11-17 · 0001213900-25-111310 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-11-16 · 0001213900-25-111298 · Items 1.01,3.03,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001213900-25-109980

  24. 8-K · Current report

    Report date 2025-10-20 · 0001213900-25-101825 · Items 1.01,1.02,2.02,8.01,9.01

  25. 8-K · Current report

    Report date 2025-09-30 · 0001213900-25-096322 · Items 8.01

  26. 8-K · Current report

    Report date 2025-08-19 · 0001213900-25-079361 · Items 5.02,5.07

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001213900-25-076668

  28. 8-K · Current report

    Report date 2025-07-22 · 0001213900-25-066819 · Items 1.01,8.01,9.01

  29. DEF 14A · Proxy statement

    Report date 2025-08-19 · 0001213900-25-064755

  30. 10-K/A · Annual report

    Report date 2024-12-31 · 0001213900-25-064678

  31. 8-K · Current report

    Report date 2025-05-21 · 0001213900-25-046436 · Items 8.01

  32. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001213900-25-044193

  33. 8-K · Current report

    Report date 2025-04-24 · 0001213900-25-036109 · Items 1.01,7.01,9.01

  34. 10-K · Annual report

    Report date 2024-12-31 · 0001013762-25-003450

  35. 8-K · Current report

    Report date 2025-02-28 · 0001213900-25-019437 · Items 1.01,9.01

  36. 8-K · Current report

    Report date 2025-02-22 · 0001213900-25-018135 · Items 1.01,9.01

  37. 8-K · Current report

    Report date 2025-02-07 · 0001213900-25-012244 · Items 1.01,7.01,9.01

  38. 8-K · Current report

    Report date 2025-01-21 · 0001213900-25-005212 · Items 1.01,9.01

  39. 8-K · Current report

    Report date 2025-01-02 · 0001213900-25-000517 · Items 1.01,9.01

  40. 8-K · Current report

    Report date 2024-12-13 · 0001213900-24-109825 · Items 8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 2 transaction rows2SGrant / award: 7 transaction rows7AExercise / conversion: 2 transaction rows2MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

26 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-24
2026-09-25
KIDRON NADAVA · Grant / award
Acquired
Common Stock368765.0n/a
2026-09-24
2026-09-25
KIDRON NADAVA · Grant / award
Acquired
Common Stock349497.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
49000.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
190000.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
196500.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
107000.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
97000.0n/a
2026-09-24
2026-09-25
KIDRON NADAVD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
150000.0n/a
2026-09-24
2026-09-25
Hexter JoshuaA · Grant / award
Acquired
Common Stock75455.0n/a
2026-09-24
2026-09-25
Hexter JoshuaA · Grant / award
Acquired
Common Stock209291.0n/a
2026-09-24
2026-09-25
Hexter JoshuaD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
50000.0n/a
2026-09-24
2026-09-25
Hexter JoshuaD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
36000.0n/a
2026-09-24
2026-09-25
Hexter JoshuaD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
50000.0n/a
2026-09-24
2026-09-25
Kidron MiriamA · Grant / award
Acquired
Common Stock209291.0n/a
2026-09-24
2026-09-25
Kidron MiriamA · Grant / award
Acquired
Common Stock208125.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
72000.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
100000.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
100000.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
69999.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
47000.0n/a
2026-09-24
2026-09-25
Kidron MiriamD · Disposition to issuer
Disposed
Stock option (right to buy)
Derivative security
104000.0n/a
2026-09-24
2026-09-25
Gabay AvrahamA · Grant / award
Acquired
Common Stock209291.0n/a
2026-07-02
2026-07-02
Hexter JoshuaM · Exercise / conversion
Acquired
Common Stock50000.03.69
2026-07-02
2026-07-02
Hexter JoshuaM · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
50000.00.0
2026-07-01
2026-07-02
Hexter JoshuaS · Sale
Disposed
Common Stock137000.04.46
2026-07-01
2026-07-02
Gabay AvrahamS · Sale
Disposed
Common Stock73360.04.51

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001176309ORAMED PHARMACEUTICALS INC.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5299006K52ZIIGQJ6R84
GLEIF legal name
Oramed Pharmaceuticals Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2021-07-14T05:31:47Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Oramed Pharmaceuticals · alias · wikidata
  • Integrated Security Technologies, Inc. · former SEC name · 2004-06-14 to 2006-04-10
  • IGUANA VENTURES LTD · former SEC name · 2002-11-29 to 2004-06-10
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2023-12-31$1.34M$1.48M
2022-12-31$2.70M$3.11M
2021-08-31$2.70M$3.43M
2020-08-31$2.71M$3.54M
2019-08-31$2.70M$3.59M
2018-08-31$2.45M$3.31M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗